Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: Phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen

David R. Parkinson, Richard I. Fisher, Anthony A. Rayner, Elisabeth Paietta, Kim A. Margolin, Geoffrey R. Weiss, James W. Mier, Mario Sznol, Ellen R. Gaynor, Michael H. Bar, Rasim Gucalp, David H. Boldt, Bonnie Mills, Michael J. Hawkins

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: Phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences